Hims & Hers Acquires Apostrophe

Hims & Hers Acquires Honest Health to Expand UK Footprint

June 14, 2021

Healthcare Services

Hims & Hers Health, Inc. agreed to acquire London-based vertical health platform Honest Health to accelerate the company's expansion into the United Kingdom and Western Europe. The acquisition adds Honest Health’s hair-loss telehealth clinic and compounding pharmacy/fulfillment capabilities to Hims & Hers’ multi-specialty telehealth platform; financial terms were not disclosed.

Hims & Hers to Go Public via Merger with Oaktree Acquisition Corp.

October 1, 2020

Healthcare Services

Hims & Hers (Hims, Inc.), a multi-specialty telehealth and consumer health platform, entered a definitive merger agreement with SPAC Oaktree Acquisition Corp. The business combination values the combined company at an approximate $1.6 billion enterprise value and provides up to $280 million of cash (including a $75 million PIPE led by Franklin Templeton and certain Oaktree clients) to accelerate Hims & Hers' growth and expansion into new care categories.

Hims & Hers Acquires US-based Peptide Facility in California

February 21, 2025

Pharmaceuticals

Hims & Hers Health, Inc. has acquired a US-based peptide manufacturing facility in California to further verticalize its supply chain and expand domestic capabilities for personalized medications. The acquisition, which closed in early February, strengthens Hims & Hers’ ability to meet growing consumer demand for personalized healthcare and peptide-based treatments.

Hims & Hers Acquires ZAVA

June 3, 2025

Healthcare Services

Hims & Hers Health, Inc. agreed to acquire ZAVA, a leading European digital health and telemedicine platform, in an all-cash transaction to accelerate the company's expansion into the UK and launch operations in Germany, France and Ireland. The acquisition brings ZAVA’s ~1.3 million active customers and nearly 2.3 million consultations in 2024 onto Hims & Hers’ platform and is expected to be accretive by 2026.

Hims & Hers Acquires MedisourceRx from Nivagen Pharmaceuticals

September 12, 2024

Pharmaceuticals

Hims & Hers has acquired MedisourceRx, the FDA-registered 503B outsourcing facility and business unit of Nivagen Pharmaceuticals. Bourne Partners served as exclusive financial adviser to Nivagen; proceeds from the sale will allow Nivagen to complete a sterile injectables facility in California and advance its pipeline.

Joi+Blokes Acquires HerMD

December 8, 2025

Healthcare Services

Nashville-based virtual clinic Joi+Blokes has acquired HerMD, a nationally recognized virtual women's health provider, combining two specialty telehealth platforms to create one of the largest virtual women’s health ecosystems in the United States. The deal expands Joi+Blokes’ national footprint and clinical capabilities—adding HerMD’s menopause and sexual-health expertise, preventative diagnostics, and expanded treatment offerings to Joi+Blokes’ existing patient base.